Free Trial

Omron Corp. (OTCMKTS:OMRNY) Sees Significant Drop in Short Interest

Omron logo with Computer and Technology background

Key Points

  • Omron Corp. experienced a noteworthy 50.2% decrease in short interest in August, bringing the total to 21,000 shares as of August 31st, which equates to 0.0% of its shares sold short.
  • Institutional investors increased stakes in Omron, with GAMMA Investing LLC raising its position by 180.8% during Q2, owning 1,488 shares valued at $40,000.
  • For Q2, Omron reported earnings of $0.24 EPS, surpassing analysts' estimates, but revenue of $1.29 billion fell short of the $1.31 billion expectation.
  • MarketBeat previews the top five stocks to own by October 1st.

Omron Corp. (OTCMKTS:OMRNY - Get Free Report) was the target of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totaling 21,000 shares, a decrease of 50.2% from the August 15th total of 42,200 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 98,600 shares, the days-to-cover ratio is presently 0.2 days. Based on an average daily volume of 98,600 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.0% of the shares of the company are sold short.

Institutional Investors Weigh In On Omron

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC lifted its position in Omron Corp. (OTCMKTS:OMRNY - Free Report) by 180.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,488 shares of the company's stock after buying an additional 958 shares during the quarter. GAMMA Investing LLC's holdings in Omron were worth $40,000 at the end of the most recent quarter. 1.09% of the stock is currently owned by institutional investors and hedge funds.

Omron Price Performance

OTCMKTS OMRNY opened at $26.79 on Friday. The company has a market cap of $5.53 billion, a PE ratio of 24.14, a price-to-earnings-growth ratio of 0.38 and a beta of 1.04. Omron has a 52 week low of $24.16 and a 52 week high of $47.75. The company has a quick ratio of 1.54, a current ratio of 2.34 and a debt-to-equity ratio of 0.13. The firm's 50-day simple moving average is $26.16 and its two-hundred day simple moving average is $27.43.

Omron (OTCMKTS:OMRNY - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.19 by $0.05. The business had revenue of $1.29 billion for the quarter, compared to the consensus estimate of $1.31 billion. Omron had a net margin of 4.04% and a return on equity of 3.46%. Research analysts predict that Omron will post 0.42 earnings per share for the current year.

About Omron

(Get Free Report)

OMRON Corporation engages in industrial automation, device and module solutions, social systems, and healthcare businesses worldwide. The Industrial Automation Business offers sensors, switches, safety and control components, relays, motion and drives, robotics, energy conservation, power supplies, and automation system products.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Omron Right Now?

Before you consider Omron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omron wasn't on the list.

While Omron currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.